Celemics, Inc. Logo

Celemics, Inc.

Develops custom NGS panels and bioinformatics for research and clinical diagnostics.

331920 | KO

Overview

Corporate Details

ISIN(s):
KR7331920009
LEI:
Country:
South Korea
Address:
서울특별시 금천구 가산디지털1로 131, A동 19층 및 20층 2004호 외, 금천구
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Celemics, Inc. is a biotechnology company specializing in Next-Generation Sequencing (NGS) solutions for research and clinical diagnostics. The company develops and manufactures a comprehensive portfolio of products, including hybridization-based NGS target enrichment panels, whole exome sequencing (WES) kits, library preparation kits, and bioinformatics analysis services. Utilizing proprietary technologies in probe design, molecular barcoding, and bioinformatics, Celemics provides both ready-to-use and fully customized panels tailored for various applications. Its key markets include oncology, liquid biopsy, biopharma, inherited disease analysis, pharmacogenomics, pathogen detection, and agrigenomics, offering end-to-end solutions from assay development to data analysis.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-13 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.2 MB
2025-05-19 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.3 MB
2025-03-27 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 24.8 KB
2025-03-27 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 10.2 KB
2025-03-19 00:00
Audit Report / Information
감사보고서제출
Korean 25.1 KB
2025-03-19 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 430.2 KB
2025-03-19 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 1.5 MB
2025-03-04 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 11.8 KB
2025-03-04 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 158.7 KB
2025-03-04 00:00
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
Korean 4.3 KB
2025-03-04 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 159.1 KB
2025-02-19 00:00
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 10.9 KB
2024-12-17 00:00
Regulatory News Service
단일판매ㆍ공급계약체결
Korean 9.6 KB
2024-11-14 00:00
Quarterly Report
분기보고서 (2024.09)
Korean 1.1 MB

Automate Your Workflow. Get a real-time feed of all Celemics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Celemics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Celemics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

HANALL BIOPHARMA CO.,LTD Logo
Develops innovative medicines for chronic diseases through antibody and small molecule research.
South Korea
009420
Hana Pharm. Co., Ltd. Logo
Pharmaceutical firm specializing in anesthetics and narcotic analgesics for global markets.
South Korea
293480
Hanmi Pharm. Co., Ltd. Logo
Biopharma firm developing innovative diabetes and cancer drugs for patients and professionals.
South Korea
128940
Hansa Biopharma Logo
Develops antibody-cleaving enzymes to treat rare diseases and enable organ transplants.
Sweden
HNSA
Harmony Biosciences Holdings, Inc. Logo
Develops innovative therapies for rare neurological diseases, focusing on conditions like narcolepsy.
United States of America
HRMY
HARROW, INC. Logo
Develops branded ophthalmic therapies and custom compounded solutions for North American eyecare.
United States of America
HROW
HCW Biologics Inc. Logo
Developing novel immunotherapies to treat aging-related chronic inflammation.
United States of America
HCWB
HEALIOS K.K. Logo
Develops iPS and somatic stem cell therapies for diseases like ARDS and cancer.
Japan
4593
Heartseed株式会社 Logo
Develops iPSC-derived cell therapies to regenerate heart tissue for heart failure.
Japan
219A
HELLENIC DYNAMICS PLC Logo
Cultivates and supplies THC-dominant medical cannabis for the European pharmaceutical market.
United Kingdom
HELD

Talk to a Data Expert

Have a question? We'll get back to you promptly.